• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Funding for antibiotic research in UK may be trailing behind resistance

byMelissa McCoyandStefan Trela
July 25, 2014
in Chronic Disease, Infectious Disease, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Out of £13.8 billion in total available research funding in the United Kingdom (UK) from 2008-2013, 0.7% (£95.0 million) of total funding was allocated to projects pertaining to antibiotic research. 

Evidence Rating Level: 3 (Average)       

Study Rundown: The rate of evolution of resistant bacteria has increased more quickly than the rate of discovery of new antibiotics with which to combat them. New antibiotics are desperately needed to battle newly resistant pathogens. This study aimed to assess whether available funding for antibiotic research in the UK has increased enough to adequately respond to this demand. Databases of agencies providing research funding in the UK were systematically searched to identify charitably and publicly funded antibiotic projects from 2008 to 2013.

This study found that of the total available research funding in the UK, bacteriology projects received 1.9% of total funding, while antibiotic research composed nearly one-third of the projects within the specialty of bacteriology or 0.7% of the total funding. Though this study provided the first assessment of charitable and public funding for bacteriology and antibiotic research in the UK, accuracy may have been compromised by reliance upon original data from the funding organizations. Based on these findings, the authors of the study suggest that current funding levels may not be enough to combat the current burden of antibiotic-resistant bacterial infections.

This study was funded by the British Society for Antimicrobial Chemotherapy.

Click to read the study, published today in The Lancet Infectious Diseases

Relevant Reading: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study

RELATED REPORTS

The Scan by 2 Minute Medicine®: Overprescribed and Understocked, A Costly Message, A Bad Wrap and Mauna Loa Erupts Again!

#VisualAbstract: Shorter antibiotic course non-inferior to longer course for pediatric community-acquired pneumonia

Virtual pediatric acute care visits within the medical home are safe and acceptable to parents

In-Depth: This study analyzed data from major UK funding organizations, the Seventh Framework Programme for Research and Technological Development (FP7) from the European Commission, and the European Union Innovative Medicines Initiative (EU IMI) to investigate the proportion of funding provided for antibiotic research from 2008-13. Research topics were categorized as: (1) tuberculosis; (2) antibiotic discovery, research and development, and mechanisms of action; (3) understanding antibiotic resistance; or (4) epidemiology of antibiotic-resistant bacteria in human being or animals. Funding data was analyzed in terms of grant value, number of grants awarded, and percentage of total grants awarded. Grants awarded in euros were converted to pounds sterling (€1=£0·86, as of Aug 20, 2013).

Of 609 projects within the specialty of bacteriology, 196 (32.2%) specifically funded antibiotic research. Out of £13.8 billion in total available research funding in the UK, £269.2 million (1.9%) funded bacteriology projects and £95.0 million (0.7%) funded antimicrobial resistance research. The Wellcome Trust provided the greatest amount of funding (£38.2 million) towards antibiotic research, whereas the Biotechnology and Biological Sciences Research Council supported the greatest number (53) of antibiotic research projects. Smaller organizations contributed a larger percentage of their total grant funding to antibiotic research, with the British Society for Antimicrobial Chemotherapy contributing the greatest percentage (80.4%, £510,064). Additionally, £181.4 million in EU funding was awarded to antibiotic research consortia based in the UK, including £96.2 million from the FP7 program and £85.2 from the EU IMI.

More from this author: Childhood tuberculosis incidence may be 25% higher than prior estimates,Adults with Asperger’s syndrome at increased risk for suicidal thoughts and behaviors,UK fails to reduce deaths of young people, Most comprehensive study to date reveals climbing worldwide obesity prevalence,Weight loss during adulthood linked with long-term cardiovascular benefits, Reduction of key risk factors could prevent 37 million deaths by 2025

Image: PD 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: antibioticsresearch
Previous Post

Shift work linked to increased risk of diabetes

Next Post

No increased overall risk of systemic events with use of anti-VEGF eye treatments

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Overprescribed and Understocked, A Costly Message, A Bad Wrap and Mauna Loa Erupts Again!

December 14, 2022
#VisualAbstract: Intensive blood pressure control post-endovascular thrombectomy after acute ischemic stroke linked with worse clinical outcomes
StudyGraphics

#VisualAbstract: Shorter antibiotic course non-inferior to longer course for pediatric community-acquired pneumonia

November 25, 2022
AAP recommends telemedicine to improve access to care
Emergency

Virtual pediatric acute care visits within the medical home are safe and acceptable to parents

November 25, 2022
#VisualAbstract: Cefepime and Enmetazobactam in treatment of urinary tract infection or acute pyelonephritis was more effective than Piperacillin and Tazobactam
StudyGraphics

#VisualAbstract: Cefepime and Enmetazobactam in treatment of urinary tract infection or acute pyelonephritis was more effective than Piperacillin and Tazobactam

October 6, 2022
Next Post
Blindness and visual impairment decreasing worldwide

No increased overall risk of systemic events with use of anti-VEGF eye treatments

Duloxetine reduces neuropathic pain in chemotherapy patients

African-American cancer patients more likely to receive risky analgesics

Video-based behavioral intervention benefits clinical skin examinations

Pain and itch associated with histologic features of skin cancers

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transcarotid artery revascularization not associated with a significant difference in 30-day risk of stroke, death and myocardial infarction compared to carotid endarterectomy
  • Drinking characteristics in adolescence predict alcohol behaviors in early adulthood
  • Sodium-glucose co-transporter-2 inhibitors may decrease risk of in-stent thrombosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options